Stock RGLS REGULUS THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

News Chart Regulus Therapeutics Inc.

Equities

RGLS

US75915K3095

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-10 pm EDT 		5-day change 1st Jan Change
2.21 USD -1.78% Intraday chart for Regulus Therapeutics Inc. -16.60% +72.66%
May. 09 Regulus Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
May. 06 Regulus Therapeutics Advances to Cohort 4 of Phase 1B Multiple-Ascending Dose Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease CI
be6b48cebb7a98fb9d.8cYaris8psCLxEgulGWBEDwKM43E9i4xKJEke3tkkX0.vb5yl3N2kvTgsA1LwSnzRls8XuqzpBxZcNdoFEID3UrHjWz8fwzw98OlHQ~26648ace0808300811603a4bc2510d01
  1. Stock Market
  2. Equities
  3. RGLS Stock
  4. Charts Regulus Therapeutics Inc.
  5. News Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW